PPD, Inc., a global CRO, opened new multipurpose lab in Suzhou, China, to support Western and China-based pharma and biopharma companies managing China research studies. The 67,000-sq.-ft. facility in the Jiangsu Province offers bioanalytical, biomarker and vaccine lab services to support trials across all phases. The company anticipates adding approximately 300 skilled professionals over the next three years. This new lab supplements the company’s existing Shanghai central lab, established in 2...